Pii has broad knowledge and technical experience in dosage form development and cGMP manufacturing
Pii presents clients with a full range of options to develop small molecules into effective pharmaceutical products. Pii’s highly trained scientific team has extensive experience working with a variety of drug substances with a range of physicochemical characteristics, including:
Poorly aqueous soluble drugs
Highly potent and cytotoxic drugs
From First-in-Man studies to commercial launch, Pii will work with you to determine the most efficient and viable pathway for your compound. Pii’s development capabilities include controlled release formulations. For poorly soluble compounds, Pii offers a variety of bioavailability enhancement technologies, including solid dispersion development, and lipid-or macro/nano-based emulsions.